BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28577105)

  • 1. Effect of Atorvastatin Therapy on the Level of CD34
    Ansheles AA; Rvacheva AV; Sergienko IV
    Bull Exp Biol Med; 2017 May; 163(1):133-136. PubMed ID: 28577105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
    Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
    Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin enhances angiogenesis to reduce subdural hematoma in a rat model.
    Wang D; Li T; Wei H; Wang Y; Yang G; Tian Y; Zhao Z; Wang L; Yu S; Zhang Y; Chen J; Jiang R; Zhang JN
    J Neurol Sci; 2016 Mar; 362():91-9. PubMed ID: 26944125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Mineralocorticoid Receptor Antagonists on Recruitment and Function of Endothelial Progenitor Cells in Patients with Congestive Heart Failure.
    Levi A; Leshem-Lev D; Weissler-Snir A; Hasin T; Mats I; Murninkas D; Kornowski R; Lev EI; Ben-Gal T
    Isr Med Assoc J; 2018 Apr; 20(4):233-238. PubMed ID: 29629731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34+CD133+CD309+ circulating angiogenic cell level is reduced but positively related to hydroxychloroquine use in SLE patients-a case-control study and meta-regression analysis.
    Huang J; Kow NY; Lee HY; Fairhurst AM; Mak A
    Rheumatology (Oxford); 2021 Aug; 60(8):3936-3944. PubMed ID: 33369679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins Therapy is Associated with Increased Populations of Early Endothelial Progenitor (CD133+/VEGFR2+) and Endothelial (CD34-/CD133- /VEGFR2+) Cells in Patients with Acute Ischemic Stroke.
    Golab-Janowska M; Paczkowska E; Machalinski B; Meller A; Kotlega D; Safranow K; Wankowicz P; Nowacki P
    Curr Neurovasc Res; 2018; 15(2):120-128. PubMed ID: 29886830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period.
    Ye H; He F; Fei X; Lou Y; Wang S; Yang R; Hu Y; Chen X
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):290-5. PubMed ID: 24346155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients.
    Lins LC; França CN; Fonseca FA; Barbosa SP; Matos LN; Aguirre AC; Bianco HT; do Amaral JB; Izar MC
    Cell Biochem Biophys; 2014 Sep; 70(1):687-96. PubMed ID: 24777811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study).
    Eisen A; Leshem-Lev D; Yavin H; Orvin K; Mager A; Rechavia E; Bental T; Dadush O; Battler A; Kornowski R; Lev EI
    Cardiovasc Drugs Ther; 2015 Apr; 29(2):129-35. PubMed ID: 25712416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics.
    Lucchinetti E; Zeisberger SM; Baruscotti I; Wacker J; Feng J; Zaugg K; Dubey R; Zisch AH; Zaugg M
    Anesth Analg; 2009 Oct; 109(4):1117-26. PubMed ID: 19762739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.
    Jaumdally RJ; Goon PK; Varma C; Blann AD; Lip GY
    J Intern Med; 2010 Apr; 267(4):385-93. PubMed ID: 19754853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes.
    Jung C; Rafnsson A; Shemyakin A; Böhm F; Pernow J
    Int J Cardiol; 2010 Sep; 143(3):368-72. PubMed ID: 19398138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Progenitor Cells and Racial Differences.
    Samman Tahhan A; Hammadah M; Kelli HM; Kim JH; Sandesara PB; Alkhoder A; Kaseer B; Gafeer MM; Topel M; Hayek SS; O'Neal WT; Obideen M; Ko YA; Liu C; Hesaroieh I; Mahar E; Vaccarino V; Waller EK; Quyyumi AA
    Circ Res; 2018 Aug; 123(4):467-476. PubMed ID: 29930146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile.
    Van Craenenbroeck EM; Vrints CJ; Haine SE; Vermeulen K; Goovaerts I; Van Tendeloo VF; Hoymans VY; Conraads VM
    J Appl Physiol (1985); 2008 Apr; 104(4):1006-13. PubMed ID: 18218912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul.
    Dome P; Teleki Z; Rihmer Z; Peter L; Dobos J; Kenessey I; Tovari J; Timar J; Paku S; Kovacs G; Dome B
    Mol Psychiatry; 2009 May; 14(5):523-31. PubMed ID: 18180758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased number of circulating progenitor cells after implantation of ventricular assist devices.
    Manginas A; Tsiavou A; Sfyrakis P; Giamouzis G; Tsourelis L; Leontiadis E; Degiannis D; Cokkinos DV; Alivizatos PA
    J Heart Lung Transplant; 2009 Jul; 28(7):710-7. PubMed ID: 19560700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keloid patients have higher peripheral blood endothelial progenitor cell counts and CD34
    Tanaka R; Umeyama Y; Hagiwara H; Ito-Hirano R; Fujimura S; Mizuno H; Ogawa R
    Int J Dermatol; 2019 Dec; 58(12):1398-1405. PubMed ID: 31290139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.
    Martini G; Biscaro F; Boscaro E; Calabrese F; Lunardi F; Facco M; Agostini C; Zulian F; Fadini GP
    BMC Musculoskelet Disord; 2015 Apr; 16():103. PubMed ID: 25925313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial progenitor cells, defined by the simultaneous surface expression of VEGFR2 and CD133, are not detectable in healthy peripheral and cord blood.
    Lanuti P; Rotta G; Almici C; Avvisati G; Budillon A; Doretto P; Malara N; Marini M; Neva A; Simeone P; Di Gennaro E; Leone A; Falda A; Tozzoli R; Gregorj C; Di Cerbo M; Trunzo V; Mollace V; Marchisio M; Miscia S
    Cytometry A; 2016 Mar; 89(3):259-70. PubMed ID: 26305912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease.
    Powell TM; Paul JD; Hill JM; Thompson M; Benjamin M; Rodrigo M; McCoy JP; Read EJ; Khuu HM; Leitman SF; Finkel T; Cannon RO
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):296-301. PubMed ID: 15569821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.